Moreover, interfering with CIN85 expression in ASAP2-knockdown HCC cells could almost restore tumor growth and invasion potentials, validating its role in ASAP2-induced c-MET activation. The gene discussed is ASAP2; the disease is hepatocellular carcinoma.